Ranking Profile - Natera Inc
Introduction
Natera Inc (Natera), formerly Gene Security Network LLC, develops genetic and cell-free deoxyribonucleic acid (cfDNA) testing solutions. The company’s products include Signatera, a personalized ctDNA (circulating tumor DNA) blood test to assess MRD (molecular residual disease) and its recurrence; Aletra, a tissue-based genomic profiling test to identify genomic alterations and oncology biomarkers in a tumor; Prospera, a transplant rejection test to evaluate the risk of rejection of a transplanted kidney. It also offers Renasight test to detect genetic cause of kidney diseases; Horizon carrier screening test; Panorama non-invasive prenatal screening test; Empower hereditary cancer test; Vistara prenatal single gene screening test; Anora miscarriage test; and Spectrum preimplantation genetic test. Natera is headquartered in Austin, Texas, the US.
Company info
Country (HQ): | United States |
Sector: | Medical Equipment |
Market Cap (US$ m): | 5,674 |
Revenue (US$ m): | 820 (2022) |
Innovation ranking
Innovation score
Closest peers in the Medical Equipment sector
Innovation Ranking
Medtronic Plc
Ireland
Medical Equipment
Boston Scientific Corp
United States
Medical Equipment
Natera Inc
United States
Medical Equipment
Savara Inc
United States
Medical Equipment
Aethlon Medical Inc
United States
Medical Equipment
Are you ranked? Get the Innovation Ranking Report
-
Company Ranking Report
- If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
- Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
- Contextualised information on the company's standing in relation to peers
- Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
- Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
- Rosettes
- Certificate of Achievement
- Press release